Upgrades:
Phillips 66 (NYSE:PSX) was upgraded by investment analysts at The Goldman Sachs Group from a “buy” rating to a “conviction-buy” rating in a research note issued on Wednesday, The Fly reports.
Several other equities research analysts also recently
issued reports on PSX. Piper Sandler upgraded Phillips 66 from a “neutral”
rating to an “overweight” rating and lifted their price objective for the stock
from $85.00 to $87.00 in a report on Wednesday, October 6th. Citigroup boosted
their price target on Phillips 66 from $75.00 to $80.00 and gave the company a
“neutral” rating in a report on Wednesday, October 6th. Royal Bank of Canada
boosted their price target on Phillips 66 from $94.00 to $95.00 and gave the
company an “outperform” rating in a report on Tuesday. Barclays lowered their
price target on Phillips 66 from $95.00 to $88.00 and set an “overweight”
rating for the company in a report on Thursday, July 8th. Finally, Morgan
Stanley boosted their price target on Phillips 66 from $90.00 to $95.00 and
gave the company an “equal weight” rating in a report on Monday. Five
investment analysts have rated the stock with a hold rating, twelve have given
a buy rating and one has given a strong buy rating to the stock. Based on data
from MarketBeat, Phillips 66 currently has an average rating of “Buy” and an
average target price of $85.63. Read
more …
Thomson Reuters (NYSE:TRI) (TSE:TRI) was upgraded by investment analysts at BNP Paribas from an “underperform” rating to a “neutral” rating in a note issued to investors on Wednesday, Price Targets.com reports.
Several other brokerages also recently weighed in on TRI. TD
Securities upgraded Thomson Reuters from a “hold” rating to a “buy” rating and
set a $160.00 price target for the company in a report on Wednesday, October
6th. Zacks Investment Research upgraded Thomson Reuters from a “hold” rating to
a “buy” rating and set a $123.00 price target for the company in a report on
Thursday, October 7th. Royal Bank of Canada downgraded Thomson Reuters from an
“outperform” rating to a “sector perform” rating and boosted their price target
for the company from $118.00 to $122.00 in a report on Monday. Morgan Stanley
boosted their price objective on shares of Thomson Reuters from $105.00 to
$106.00 and gave the company an “equal weight” rating in a research note on
Thursday, September 23rd. Finally, National Bank Financial boosted their price
objective on shares of Thomson Reuters from C$145.00 to C$162.00 and gave the
company a “sector perform” rating in a research note on Thursday, September
2nd. Seven investment analysts have rated the stock with a hold rating and four
have given a buy rating to the company. According to MarketBeat, the company
currently has a consensus rating of “Hold” and an average target price of
$125.90. Read
more …
QUALCOMM (NASDAQ:QCOM) was upgraded by research analysts at The Goldman Sachs Group from a “neutral” rating to a “buy” rating in a research note issued to investors on Thursday, The Fly reports.
A number of other research analysts also recently issued
reports on the company. Canaccord Genuity reissued a “buy” rating and issued a
$225.00 price objective (up from $200.00) on shares of QUALCOMM in a research
note on Thursday, August 12th. Cowen boosted their target price on QUALCOMM
from $180.00 to $185.00 and gave the company an “outperform” rating in a
research report on Thursday, July 29th. Susquehanna reaffirmed a “hold” rating
and issued a $157.00 target price on shares of QUALCOMM in a research report on
Thursday, July 29th. Zacks Investment Research lowered QUALCOMM from a “buy”
rating to a “hold” rating and set a $135.00 target price for the company. in a
research report on Monday, October 4th. Finally, Mizuho decreased their target
price on QUALCOMM from $180.00 to $165.00 and set a “buy” rating for the
company in a research report on Tuesday, October 19th. Thirteen equities
research analysts have rated the stock with a hold rating, sixteen have
assigned a buy rating and one has assigned a strong buy rating to the company.
According to data from MarketBeat.com, the stock currently has an average
rating of “Buy” and an average price target of $166.77. Read
more…
GlaxoSmithKline (NYSE:GSK) was upgraded by stock analysts at Barclays from an "underweight" rating to an "equal weight" rating in a research note issued on Friday, The Fly reports.
GSK has been the topic of several other research reports.
Morgan Stanley reaffirmed an "equal weight" rating on shares of
GlaxoSmithKline in a report on Wednesday. JPMorgan Chase & Co. reaffirmed a
"neutral" rating on shares of GlaxoSmithKline in a report on Monday.
Berenberg Bank reaffirmed a "buy" rating on shares of GlaxoSmithKline
in a report on Monday, October 18th. Zacks Investment Research downgraded
shares of GlaxoSmithKline from a "hold" rating to a "sell"
rating and set a $41.00 target price on the stock. in a report on Tuesday, July
20th. Finally, UBS Group reaffirmed a "neutral" rating on shares of
GlaxoSmithKline in a report on Monday, September 20th. Two equities research
analysts have rated the stock with a sell rating, six have issued a hold rating
and three have given a buy rating to the company. Based on data from
MarketBeat.com, the stock currently has a consensus rating of "Hold"
and a consensus price target of $41.00.
GlaxoSmithKline stock opened at $43.00 on Friday. The
company has a debt-to-equity ratio of -0.95, a current ratio of 0.81 and a
quick ratio of 0.54. The business has a 50 day simple moving average of $39.81
and a 200-day simple moving average of $39.66. GlaxoSmithKline has a 12 month
low of $33.53 and a 12 month high of $43.61. The stock has a market
capitalization of $115.78 billion, a PE ratio of 18.22, a
price-to-earnings-growth ratio of 2.57 and a beta of 0.72. Read
more …
Devon Energy (NYSE:DVN) was upgraded by investment analysts at Benchmark from a “hold” rating to a “buy” rating in a research note issued on Wednesday, The Fly reports.
Several other research firms have also commented on DVN.
Mizuho upped their price objective on Devon Energy from $38.00 to $59.00 and
gave the stock a “buy” rating in a research report on Tuesday, October 26th.
Truist Securities upped their price objective on Devon Energy from $42.00 to
$52.00 and gave the stock a “buy” rating in a research report on Thursday,
October 7th. The Goldman Sachs Group lowered Devon Energy from a
“conviction-buy” rating to a “buy” rating in a research report on Thursday,
September 9th. Zacks Investment Research lowered Devon Energy from a
“strong-buy” rating to a “hold” rating and set a $32.00 price objective on the
stock. in a research report on Friday, September 17th. Finally, Morgan Stanley
upped their price objective on Devon Energy from $34.00 to $37.00 and gave the
stock an “equal weight” rating in a research report on Wednesday, October 6th.
Three analysts have rated the stock with a hold rating, sixteen have assigned a
buy rating and one has given a strong buy rating to the company’s stock.
According to MarketBeat.com, the company currently has a consensus rating of
“Buy” and a consensus price target of $36.99. Read
more …
WEC Energy Group (NYSE:WEC) was upgraded by research analysts at Scotiabank from a “sector perform” rating to a “sector outperform” rating in a report released on Wednesday, Price Targets.com reports. The brokerage presently has a $109.00 price target on the utilities provider’s stock, up from their prior price target of $104.00. Scotiabank’s price target suggests a potential upside of 22.61% from the company’s current price.
A number of other research firms have also recently
commented on WEC. Wolfe Research raised WEC Energy Group from an “underperform”
rating to a “peer perform” rating in a report on Tuesday, October 19th. Bank of
America raised WEC Energy Group from an “underperform” rating to a “neutral”
rating and boosted their price target for the stock from $92.00 to $94.00 in a
report on Friday, October 15th. Argus boosted their price target on WEC Energy
Group from $100.00 to $104.00 and gave the stock a “buy” rating in a report on
Wednesday, September 1st. Finally, Mizuho boosted their price target on WEC
Energy Group from $94.00 to $95.00 and gave the stock a “neutral” rating in a
report on Thursday, August 26th. Three equities research analysts have rated
the stock with a hold rating and four have given a buy rating to the company.
Based on data from MarketBeat, the stock presently has an average rating of
“Buy” and a consensus price target of $101.33. Read
more …
DuPont de Nemours (NYSE:DD) was upgraded by research analysts at Credit Suisse Group from a “neutral” rating to an “outperform” rating in a research note issued on Wednesday, The Fly reports. The brokerage presently has a $95.00 target price on the basic materials company’s stock, up from their prior target price of $76.00. Credit Suisse Group’s target price would suggest a potential upside of 17.84% from the company’s previous close.
Other equities research analysts have also issued reports
about the stock. TheStreet raised shares of DuPont de Nemours from a “d+”
rating to a “c” rating in a report on Tuesday, August 3rd. Zacks Investment
Research upgraded shares of DuPont de Nemours from a “hold” rating to a “buy”
rating and set a $74.00 target price on the stock in a research report on
Tuesday, October 5th. KeyCorp reiterated a “buy” rating and set a $93.00 target
price on shares of DuPont de Nemours in a research report on Thursday,
September 16th. Vertical Research upgraded shares of DuPont de Nemours from a
“hold” rating to a “buy” rating and set a $95.00 target price on the stock in a
research report on Wednesday. Finally, Mizuho started coverage on shares of
DuPont de Nemours in a research report on Tuesday, October 12th. They set a
“buy” rating and a $94.00 target price on the stock. Nine analysts have rated
the stock with a hold rating and thirteen have assigned a buy rating to the
company’s stock. According to data from MarketBeat.com, DuPont de Nemours has a
consensus rating of “Buy” and an average target price of $90.43. Read
more …
Downgrades:
Exxon Mobil (NYSE:XOM) was downgraded by analysts at Truist Securities from a "hold" rating to a "sell" rating in a report released on Tuesday, Price Targets.com reports. They presently have a $50.00 price target on the oil and gas company's stock, down from their previous price target of $66.00. Truist Securities' target price suggests a potential downside of 23.56% from the company's previous close.
Other research analysts have also recently issued research
reports about the stock. Wells Fargo & Company lifted their target price on
shares of Exxon Mobil from $71.00 to $75.00 and gave the company an
"overweight" rating in a research note on Monday. Piper Sandler
boosted their price objective on shares of Exxon Mobil from $63.00 to $69.00
and gave the stock a "neutral" rating in a research report on Friday,
July 23rd. They noted that the move was a valuation call. Truist cut shares of
Exxon Mobil from a "hold" rating to a "sell" rating and
dropped their target price for the company from $66.00 to $50.00 in a research
report on Tuesday. HSBC decreased their price target on shares of Exxon Mobil
from $65.00 to $57.00 and set a "hold" rating for the company in a
report on Thursday, July 22nd. Finally, BMO Capital Markets began coverage on
shares of Exxon Mobil in a report on Monday, July 12th. They issued a
"market perform" rating and a $69.00 price target for the company.
Five investment analysts have rated the stock with a sell rating, twelve have
given a hold rating, six have given a buy rating and one has assigned a strong
buy rating to the stock. According to MarketBeat.com, Exxon Mobil presently has
a consensus rating of "Hold" and an average target price of $61.94. Read
more …
Magellan Midstream Partners (NYSE:MMP) was downgraded by Citigroup from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday, Price Targets.com reports.
MMP has been the subject of several other reports. Raymond
James boosted their price target on Magellan Midstream Partners from $50.00 to
$51.00 and gave the stock an “outperform” rating in a research report on
Monday, October 18th. Barclays boosted their price target on Magellan Midstream
Partners from $50.00 to $53.00 and gave the stock an “overweight” rating in a
research report on Tuesday, October 19th. Bank of America started coverage on
Magellan Midstream Partners in a research report on Tuesday, September 28th.
They issued an “underperform” rating for the company. Finally, Mizuho boosted
their target price on Magellan Midstream Partners from $47.00 to $50.00 and
gave the stock a “neutral” rating in a research note on Friday, July 30th. One
analyst has rated the stock with a sell rating, twelve have assigned a hold
rating and three have issued a buy rating to the company. According to
MarketBeat.com, the stock has an average rating of “Hold” and an average target
price of $49.00. Read
more …
Novo Nordisk A/S (NYSE:NVO) was downgraded by analysts at Bryan, Garnier & Co from a “buy” rating to a “sell” rating in a research report issued on Wednesday, The Fly reports. They presently have a 592.00 target price on the stock.
A number of other research firms have also weighed in on
NVO. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Novo
Nordisk A/S in a research report on Monday. Citigroup reaffirmed a “buy” rating
on shares of Novo Nordisk A/S in a research report on Monday, August 23rd. UBS
Group reaffirmed a “neutral” rating on shares of Novo Nordisk A/S in a research
report on Tuesday, August 17th. SEB Equities raised shares of Novo Nordisk A/S
from a “hold” rating to a “buy” rating in a research report on Monday, October
18th. Finally, Berenberg Bank reaffirmed a “hold” rating on shares of Novo
Nordisk A/S in a research report on Friday, September 3rd. Three research
analysts have rated the stock with a sell rating, five have issued a hold
rating and six have given a buy rating to the stock. Based on data from
MarketBeat.com, Novo Nordisk A/S has an average rating of “Hold” and an average
price target of $341.50. Read
more …
Starbucks (NASDAQ:SBUX) was downgraded by stock analysts at Argus from a "buy" rating to a "hold" rating in a research note issued on Thursday, The Fly reports.
Several other research firms have also weighed in on SBUX.
Morgan Stanley lowered their price objective on Starbucks from $124.00 to
$117.00 and set an "equal weight" rating on the stock in a research
note on Friday, October 29th. Wedbush lowered their price objective on
Starbucks from $132.00 to $128.00 and set an "outperform" rating on
the stock in a research note on Friday, October 29th. Oppenheimer lowered their
price objective on Starbucks from $140.00 to $130.00 and set an
"outperform" rating on the stock in a research note on Friday,
October 29th. Credit Suisse Group lowered their price objective on Starbucks
from $137.00 to $132.00 and set an "outperform" rating on the stock
in a research note on Friday, October 29th. Finally, BMO Capital Markets
reduced their target price on Starbucks from $140.00 to $135.00 and set an
"outperform" rating on the stock in a report on Friday, October 29th.
Ten equities research analysts have rated the stock with a hold rating and
nineteen have assigned a buy rating to the stock. Based on data from
MarketBeat.com, Starbucks presently has a consensus rating of "Buy"
and a consensus target price of $123.00.
Shares of SBUX opened at $112.61 on Thursday. Starbucks has
a 12-month low of $88.74 and a 12-month high of $126.32. The firm has a market
capitalization of $132.78 billion, a price-to-earnings ratio of 31.72, a P/E/G
ratio of 1.58 and a beta of 0.84. The stock's 50-day moving average price is
$113.80 and its 200 day moving average price is $114.70. Read
more …
BCE (NYSE:BCE) (TSE:BCE) was downgraded by stock analysts at TD Securities from a “buy” rating to a “hold” rating in a note issued to investors on Friday, Price Targets.com reports.
A number of other brokerages have also recently weighed in
on BCE. Royal Bank of Canada increased their target price on shares of BCE from
$61.00 to $63.00 and gave the stock a “sector perform” rating in a report on
Friday, August 6th. BMO Capital Markets increased their target price on shares
of BCE from C$61.50 to C$63.50 and gave the stock an “outperform” rating in a
report on Friday, August 6th. Scotiabank increased their target price on shares
of BCE from C$63.00 to C$66.00 and gave the stock an “outperform” rating in a
report on Friday, August 6th. Finally, Canaccord Genuity raised shares of BCE
from a “hold” rating to a “buy” rating and increased their target price for the
stock from $62.00 to $66.00 in a report on Thursday, August 5th. One research
analyst has rated the stock with a sell rating, five have assigned a hold rating
and four have assigned a buy rating to the stock. According to data from
MarketBeat, the stock has a consensus rating of “Hold” and an average target
price of $60.45. Read
more …
B&G Foods (NYSE:BGS) was downgraded by research analysts at Piper Sandler from a "neutral" rating to an "underweight" rating in a research note issued on Friday, The Fly reports. They presently have a $27.00 price target on the stock. Piper Sandler's target price would indicate a potential downside of 16.95% from the company's previous close.
BGS stock opened at $32.51 on Friday. The company has a
market cap of $2.11 billion, a P/E ratio of 19.12 and a beta of 0.34. B&G
Foods has a 52 week low of $25.26 and a 52 week high of $47.84. The company's
50-day moving average price is $29.94 and its 200 day moving average price is
$30.33. The company has a current ratio of 3.43, a quick ratio of 0.99 and a
debt-to-equity ratio of 2.76.
B&G Foods (NYSE:BGS) last released its quarterly
earnings data on Thursday, August 5th. The company reported $0.41 EPS for the
quarter, missing analysts' consensus estimates of $0.44 by ($0.03). The company
had revenue of $464.38 million for the quarter, compared to analysts' expectations
of $436.93 million. B&G Foods had a return on equity of 15.71% and a net
margin of 5.59%. On average, equities research analysts expect that B&G
Foods will post 1.96 earnings per share for the current year. Read
more …
Novartis (NYSE:NVS) was downgraded by equities research analysts at UBS Group from a "buy" rating to a "neutral" rating in a research note issued to investors on Friday, The Fly reports.
A number of other equities analysts have also recently
issued reports on NVS. JPMorgan Chase & Co. reiterated an
"underweight" rating on shares of Novartis in a report on Wednesday,
October 27th. Deutsche Bank Aktiengesellschaft cut Novartis from a
"hold" rating to a "sell" rating in a report on Monday,
September 20th. Zacks Investment Research cut Novartis from a "hold"
rating to a "sell" rating and set a $96.00 price objective for the
company. in a report on Monday, July 26th. Finally, Berenberg Bank reiterated a
"buy" rating on shares of Novartis in a report on Tuesday, October
12th. Four analysts have rated the stock with a sell rating, four have given a
hold rating and four have issued a buy rating to the company. Based on data
from MarketBeat.com, the stock presently has an average rating of "Hold"
and an average target price of $104.33.
Shares of NYSE NVS opened at $83.69 on Friday. The firm has
a market capitalization of $187.19 billion, a P/E ratio of 19.33, a P/E/G ratio
of 2.01 and a beta of 0.55. The company has a quick ratio of 0.65, a current
ratio of 0.88 and a debt-to-equity ratio of 0.41. The stock's 50-day simple
moving average is $84.77 and its two-hundred day simple moving average is
$88.62. Novartis has a twelve month low of $81.01 and a twelve month high of
$98.52. Read
more …
Comments
Post a Comment